What are the types, dosing intervals, and side effects of nitrates, such as nitroglycerin (sublingual) and isosorbide mononitrate, in the management of angina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrates in Angina Management: Types, Dosing, and Side Effects

Nitrates are essential vasodilators for both acute symptom relief and prophylaxis of angina, with different formulations requiring specific dosing intervals to prevent tolerance and maintain efficacy. 1

Types of Nitrates and Their Characteristics

Short-Acting Nitrates

  • Nitroglycerin (NTG) sublingual tablets: 0.3-0.6 mg (up to 1.5 mg), with effect duration of 1-7 minutes; should be dissolved under the tongue at first sign of angina attack 1
  • NTG spray: 0.4 mg as needed, with similar duration to sublingual tablets 1
  • These formulations provide rapid symptom relief for acute angina attacks and can be used prophylactically 5-10 minutes before activities that might trigger angina 2

Long-Acting Nitrates

  • Isosorbide dinitrate (ISDN):

    • Oral: 5-80 mg, 2-3 times daily (duration up to 8 hours) 1
    • Oral slow-release: 40 mg 1-2 times daily (duration up to 8 hours) 1
  • Isosorbide mononitrate (ISMN):

    • Oral: 20 mg twice daily (duration 12-24 hours) 1
    • Oral slow-release: 60-240 mg once daily 1, 3
  • Other nitrates:

    • Transdermal NTG: 0.2-0.8 mg/hour every 12 hours (duration 8-12 hours during intermittent therapy) 1
    • Intravenous NTG: 5-200 mcg/min (tolerance develops in 7-8 hours) 1
    • Pentaerythritol tetranitrate: 10 mg sublingual as needed 1
    • Erythritol tetranitrate: 5-10 mg sublingual as needed or 10-30 mg oral three times daily 1

Mechanism of Action

  • Nitrates act as endothelium-independent vasodilators with both peripheral and coronary vascular effects 1
  • They primarily dilate capacitance vessels, decreasing cardiac preload and reducing ventricular wall tension 1
  • Additional effects include:
    • Modest arterial circulation effects resulting in afterload reduction 1
    • Dilation of normal and atherosclerotic coronary arteries 1
    • Increased coronary collateral flow 1
    • Possible inhibition of platelet aggregation 1

Dosing Intervals and Administration Guidelines

Sublingual Nitroglycerin

  • One tablet (0.3-0.6 mg) should be dissolved under the tongue at first sign of angina 2
  • Dose may be repeated approximately every 5 minutes until relief is obtained 2
  • If pain persists after 3 tablets in a 15-minute period, or if pain differs from typical angina, immediate medical attention is recommended 2

Intravenous Nitroglycerin

  • Initiate at 10 mcg/min via continuous infusion through non-absorbing tubing 1
  • Increase by 10 mcg/min every 3-5 minutes until symptom relief or blood pressure response is noted 1
  • If no response at 20 mcg/min, use increments of 10 and later 20 mcg/min 1
  • Maximum recommended dose is typically 200 mcg/min 1

Long-Acting Oral Nitrates

  • Critical concept: To prevent tolerance, a daily nitrate-free interval of 10-12 hours is required 1
  • For isosorbide mononitrate extended-release: Once-daily dosing (60-240 mg) in the morning is recommended 3, 4
  • For isosorbide dinitrate: Appropriate timing of doses to ensure a nitrate-free interval 1

Transdermal Nitroglycerin

  • Patches should be removed for part of the day or night to create a nitrate-free interval 1
  • Continuous 24-hour therapy is not effective due to tolerance development 1

Side Effects and Precautions

Common Side Effects

  • Headache (dose-dependent) 1
  • Flushing 1
  • Hypotension, especially postural 1, 2
  • Reflex tachycardia 1

Serious Adverse Effects and Precautions

  • Severe hypotension can occur, particularly with upright posture 2
  • Paradoxical bradycardia and increased angina may accompany nitrate-induced hypotension 2
  • Nitrates may aggravate angina caused by hypertrophic cardiomyopathy 2
  • Contraindicated with phosphodiesterase inhibitors (sildenafil, vardenafil, tadalafil) due to risk of profound hypotension 2
  • Should be avoided in patients with:
    • Initial systolic BP <90 mmHg or ≥30 mmHg below baseline 1
    • Marked bradycardia or tachycardia 1
    • Right ventricular infarction 1

Nitrate Tolerance

  • Tolerance is dose and duration dependent, typically developing after 24 hours of continuous therapy 1
  • Mechanisms to prevent tolerance:
    • Provide a daily "nitrate-free interval" of 10-12 hours 1, 4
    • Use appropriate timing of doses for intermediate-acting ISDN 1
    • Use formulations of ISMN that provide suitable plasma concentration profiles 1
    • For transdermal patches, remove during part of the day or night 1
  • When tolerance develops during continuous IV therapy, responsiveness can often be restored by:
    • Increasing the dose 1
    • Adding a nitrate-free interval after symptoms have been controlled for several hours 1

Clinical Applications and Recommendations

  • Short-acting nitrates are effective for immediate relief of acute angina attacks 1
  • Long-acting nitrates reduce frequency and severity of anginal attacks and may increase exercise tolerance 1
  • Intravenous nitroglycerin is beneficial in patients with heart failure, hypertension, or symptoms not relieved by sublingual nitroglycerin and beta-blockers 1
  • For patients requiring continued IV nitroglycerin beyond 24 hours, convert to oral or topical nitrates within 24 hours when stabilized 1
  • Patients should be instructed that angina not responding to short-acting nitroglycerin may represent myocardial infarction 1

Pitfalls to Avoid

  • Continuous nitrate therapy without a nitrate-free interval leads to tolerance 1, 5
  • Excessive dosing can cause severe headaches and significant hypotension 2
  • Concomitant use with phosphodiesterase inhibitors can cause dangerous hypotension 2
  • Patients should be seated when taking sublingual nitroglycerin to prevent falls from lightheadedness 2
  • Nitroglycerin tablets must be kept in the original glass container and tightly capped after each use to prevent loss of potency 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.